» Authors » A Cecchettini

A Cecchettini

Explore the profile of A Cecchettini including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 19
Citations 191
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lomonaco T, Persiani E, Biagini D, Gisone I, Ceccherini E, Cecchettini A, et al.
Ecotoxicol Environ Saf . 2024 Jul; 282:116695. PMID: 38981390
Microplastics (MPs) are recognized as a major environmental problem due to their ubiquitous presence in ecosystems and bioaccumulation in food chains. Not only humans are continuously exposed to these pollutants...
2.
Ceccherini E, Gisone I, Persiani E, Ippolito C, Falleni A, Cecchettini A, et al.
Front Pharmacol . 2024 Feb; 15:1330374. PMID: 38344172
Vascular calcification is a pathological chronic condition characterized by calcium crystal deposition in the vessel wall and is a recurring event in atherosclerosis, chronic kidney disease, and diabetes. The lack...
3.
Vozzi F, Cecchettini A, Cabiati M, Mg F, Aretini P, Del Ry S, et al.
Biomed Mater . 2021 May; 16(4). PMID: 34020430
Drug-eluting bioresorbable vascular scaffolds (BVSs) have emerged as a potential breakthrough for the treatment of coronary artery stenosis, providing mechanical support and drug delivery followed by complete resorption. Restenosis and...
4.
Ucciferri N, Rocchiccioli S, Comelli L, Marconi M, Ferrari M, Pelosi G, et al.
Talanta . 2017 Jul; 174:341-346. PMID: 28738590
Extracellular matrix (ECM) is a fundamental component of multicellular organisms. Alteration of its structure and/or molecular composition are associated with several pathologies, among the others with atherosclerosis. To determine how...
5.
Della Latta V, Cecchettini A, Del Ry S, Morales M
Pharmacol Res . 2015 May; 97:122-30. PMID: 25959210
Bleomycin (BLM) is a drug used to treat different types of neoplasms. BLM's most severe adverse effect is lung toxicity, which induces remodeling of lung architecture and loss of pulmonary...
6.
Cecchettini A, Scarcelli V, Locci M, Masetti M, Giorgi F
Arthropod Struct Dev . 2007 Dec; 30(3):243-50. PMID: 18088959
A panel of monoclonal antibodies was raised against late yolk sacs of the stick insect Carausius morosus and tested by immunoblotting to establish the extent vitellin polypeptides are processed proteolytically...
7.
Di Primio C, Marracci S, Cecchettini A, Nardi I, Giorgi F, Fausto A, et al.
Micron . 2006 Jul; 38(3):268-77. PMID: 16824766
This study is aimed at demonstrating the role played by a calpastatin isoform (Xcalp3) in Xenopus embryos. A specific monoclonal antibody (mAb) was raised against a glutathione S-transferase (GST)-Xcalp3 fusion...
8.
Fausto A, Gambellini G, Mazzini M, Cecchettini A, Locci M, Masetti M, et al.
Dev Growth Differ . 2001 Dec; 43(6):725-33. PMID: 11737153
In mid-embryogenesis, the stick insect Carausius morosus comes to be comprised of three distinct districts: the embryo proper, the yolk sac and the perivitelline fluid. A monolayered epithelium, the so-called...
9.
Fausto A, Gambellini G, Mazzini M, Cecchettini A, Masetti M, Giorgi F
Cell Tissue Res . 2001 Sep; 305(3):433-43. PMID: 11572096
Newly laid eggs of stick insects comprise a unique fluid ooplasm that is gradually partitioned into a number of yolk granules by invasion of secondary vitellophages. This study aimed at...
10.
Cecchettini A, Falleni A, Gremigni V, Locci M, Masetti M, Bradley J, et al.
Eur J Cell Biol . 2001 Aug; 80(7):458-65. PMID: 11499788
This study investigates the developmental fate of vitellin (Vt) polypeptides generated by limited proteolysis in an insect embryo. To this end, a number of polyclonal (pAb) and monoclonal antibodies (mAb)...